Infosys BPM in the News

Infosys McCamish Recognized as a Leader in Gartner’s Magic Quadrant for Life Insurance Policy Administration Systems in North America

Bengaluru, India - December 14, 2018

Infosys McCamish Systems, a U.S. based subsidiary of Infosys, has been recognized as a Leader in Gartner’s Magic Quadrant for Life Insurance Policy Administration Systems for North America.

The VPAS® Platform of Infosys McCamish supports 35 production customers in North America and provides support for Life & Annuity products, including individual and group, variable, fixed, indexed and repetitive payment products, as well as health and welfare products.

Gartner’s Magic Quadrant evaluated vendors that provide Policy Administration Systems (PAS) for individual and group life and annuity products, on two primary criteria – ‘completeness of vision’ and ‘ability to execute’.

According to the report, Leaders have the highest combined scores of ability to execute and completeness of vision. They have proven digital capabilities with modern architectures. Leaders have proven track records with an adequate installed customer base, sufficient resources to penetrate their markets and a high degree of customer satisfaction. They are executing on new or alternative deployment models, developing innovative system implementation approaches, and are thought leaders in the application of advanced technologies in their policy administration systems.

An excerpt of the report can be accessed here.

Source: Gartner, Magic Quadrant for Life Insurance Policy Administration Systems, North America, Richard Natale, 22 August 2018

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.